The phrase "available to validate the" is correct and usable in written English.
It can be used when referring to resources, tools, or individuals that can confirm or authenticate something.
Example: "The data is available to validate the findings of the research study."
Alternatives: "ready to confirm the" or "accessible to verify the".
However, no scientific data is available to validate the folklore claim.
In addition to helping states and local governments prevent that hacking, she said her department was working to ensure that methods were available to validate the vote if a cyberattack occurred.
The union said that committee members said that they would help obtain the necessary information from the World Anti-Doping Agency, which has said that more than enough information is available to validate the test.
This ship has been widely investigated in the context of different research projects and a large amount of data (both measurements and numerical calculations) is available to validate the solution approach and to highlight the benefits, as well as the weaknesses, of the proposed coupled BEM/RANS approach versus established but computationally demanding calculations based only on RANS simulations.
During the exploitation phase, no reference field will be available to validate the DIFI chain output.
Unfortunately, few objective data are available to validate the clinical epidemiology of surgical and device-related infections, and although the number of randomized trials is increasing, too few have tested strategies for prophylaxis or treatment, particularly in the cardiac arena.
Although no data are available to validate these calculations, the measurements of Nath and Chopra [18] for the thermal conductivity of thin films of copper (also plotted in Figure 1) clearly show a decrease in the thermal conductivity as the thickness of the film decreases.
Note that no reference sequence is used to compute the FRC curve, which makes the FRC a useful tool in de novo sequencing project where a reference genome is not available to validate and guide the assembly process.
There have been limited data available to validate or reject the potential benefit of EGCG in RA patients.
This is a problem because now that there is finally some progress towards identifying the genes involved (Kerkvliet et al. 2017; Mann and Jackson 2014; Richards et al. 2013), it is important that laboratory crosses are available, to validate prior knowledge on the inheritance and for use in fine mapping recombination break-points.
